-
Product Insights
NewAlpha Galactosidase A – Drugs In Development, 2024
The Alpha Galactosidase A pipeline drugs market research report outlays comprehensive information on the Alpha Galactosidase A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Fabry Disease. It also reviews key players involved in Alpha Galactosidase A targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...
-
Product Insights
NewAdenosine Receptor A2b – Drugs In Development, 2024
The Adenosine Receptor A2b pipeline drugs market research report outlays comprehensive information on the Adenosine Receptor A2b targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Infectious Disease, and Cardiovascular which include indications of Solid Tumor, Colorectal Cancer, Asthma, Pulmonary Fibrosis, Sepsis, Clostridioides difficile Infections (Clostridium difficile Associated Disease), Myocardial Infarction, and Atherosclerosis. It also reviews...
-
Product Insights
NewCalcium Activated Neutral Protease – Drugs In Development, 2024
The Calcium Activated Neutral Protease pipeline drugs market research report outlays comprehensive information on the Calcium Activated Neutral Protease targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Ophthalmology, Musculoskeletal Disorders, and Respiratory which include indications of Traumatic Brain Injury, Alzheimer's Disease, Ophthalmology, Glaucoma, Limb-Girdle Muscular Dystrophy, and Pulmonary Fibrosis. It also reviews key players...
-
Product Insights
NewDual Specificity Mitogen Activated Protein Kinase Kinase 1 – Drugs In Development, 2024
The Dual Specificity Mitogen Activated Protein Kinase Kinase 1 pipeline drugs market research report outlays comprehensive information on the Dual Specificity Mitogen Activated Protein Kinase Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genetic Disorders, Non Malignant Disorders, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Neurofibromatoses Type...
-
Product Insights
NewHistone Lysine N Methyltransferase EZH2 – Drugs In Development, 2024
The Histone Lysine N Methyltransferase EZH2 pipeline drugs market research report outlays comprehensive information on the Histone Lysine N Methyltransferase EZH2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Respiratory Syncytial Virus (RSV) Infections. It also reviews key players involved in Histone...
-
Product Insights
NewPhosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Gamma Isoform – Drugs In Development, 2024
The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Gamma Isoform pipeline drugs market research report outlays comprehensive information on the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Gamma Isoform targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Infectious Disease, and Immunology which include indications of Solid Tumor, Ovarian Cancer, Asthma, Chronic Obstructive Pulmonary Disease (COPD),...
-
Product Insights
NewTumor Necrosis Factor Receptor Superfamily Member 10B – Drugs In Development, 2024
The Tumor Necrosis Factor Receptor Superfamily Member 10B pipeline drugs market research report outlays comprehensive information on the Tumor Necrosis Factor Receptor Superfamily Member 10B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Immunology, and Hematological Disorders which include indications of Oncology, Solid Tumor, Respiratory, Malignant Pleural Effusion, Autoimmune Disorders, Systemic Sclerosis (Scleroderma), and Hematological...
-
Product Insights
NewEndothelin 1 Receptor – Drugs In Development, 2024
The Endothelin 1 Receptor pipeline drugs market research report outlays comprehensive information on the Endothelin 1 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Genito Urinary System, Ophthalmology, and Genetic Disorders which include indications of Pulmonary Arterial Hypertension, Portal Hypertension, Chronic Kidney Disease (Chronic Renal Failure), Diabetic Nephropathy, Diabetic Retinopathy, Open-Angle Glaucoma, and Alport Syndrome....
-
Product Insights
NewLanosterol 14 Alpha Demethylase – Drugs In Development, 2024
The Lanosterol 14 Alpha Demethylase pipeline drugs market research report outlays comprehensive information on the Lanosterol 14 Alpha Demethylase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Ophthalmology, Oncology, and Respiratory which include indications of Aspergillosis, Fungal Infections, Age Related Macular Degeneration, Eye Infections, Oncology, Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma...
-
Product Insights
NewHepatocyte Growth Factor – Drugs In Development, 2024
The Hepatocyte Growth Factor pipeline drugs market research report outlays comprehensive information on the Hepatocyte Growth Factor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Cardiovascular, and Gastrointestinal which include indications of Amyotrophic Lateral Sclerosis, Diabetic Peripheral Neuropathy, Oncology, Ovarian Cancer, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Peripheral Arterial Disease (PAD)/ Peripheral...